📅Offer Date: 08 Dec 2025 – 10 Dec 2025
Data sourced from BSE & NSE · Last updated
Corona Remedies Limited IPO was subscribed 144.49x in total when bidding closed on 10 Dec 2025, with 293.80x in the QIB category, 220.18x in NII, 30.29x in retail. The issue ran from 08 Dec 2025 to 10 Dec 2025 at a price band of ₹1008.00–₹1062.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (30.29x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 12,21,729 | 35,89,43,980 | 293.80x |
| NIIs | 9,16,960 | 20,18,96,253 | 220.18x |
| SNIIs (<10L) | 3,05,653 | 5,11,05,182 | 167.20x |
| BNIIs (>10L) | 6,11,307 | 15,07,91,098 | 246.67x |
| Retail | 21,39,573 | 6,48,07,666 | 30.29x |
| Total | 43,36,298 | 62,65,51,698 | 144.49x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 129.75 | 38119.85 | 293.80x |
| NIIs | 97.38 | 21441.38 | 220.18x |
| Retail | 227.22 | 6882.57 | 30.29x |
| Total | 454.35 | 66443.81 | 144.49x |
Values derived from share count × issue price (₹1062.00)
Because Corona Remedies Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.